Thomas C. Manning

785 total citations
16 papers, 658 citations indexed

About

Thomas C. Manning is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Thomas C. Manning has authored 16 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Thomas C. Manning's work include Monoclonal and Polyclonal Antibodies Research (5 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). Thomas C. Manning is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). Thomas C. Manning collaborates with scholars based in United States and Italy. Thomas C. Manning's co-authors include David M. Kranz, Carol J. Schlueter, Luc Teyton, Svetlana A. Mikheeva, Robert Rostomily, John R. Silber, Jeffrey A. Speir, Ian A. Wilson, Thomas C. Brodnicki and K. Christopher García and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and The Journal of Immunology.

In The Last Decade

Thomas C. Manning

16 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas C. Manning United States 11 341 231 198 104 64 16 658
Nakayuki Honma Japan 14 366 1.1× 207 0.9× 125 0.6× 41 0.4× 51 0.8× 19 622
Paula Boutin United States 11 196 0.6× 216 0.9× 120 0.6× 44 0.4× 50 0.8× 13 487
Angela Burman United Kingdom 11 450 1.3× 119 0.5× 181 0.9× 43 0.4× 22 0.3× 14 757
Mobin Karimi United States 11 524 1.5× 291 1.3× 414 2.1× 42 0.4× 46 0.7× 32 927
Mitali Manzur Australia 10 386 1.1× 376 1.6× 254 1.3× 34 0.3× 136 2.1× 12 885
Natalie Fadle Germany 16 301 0.9× 353 1.5× 114 0.6× 89 0.9× 29 0.5× 38 780
Federica Costa Italy 16 203 0.6× 302 1.3× 376 1.9× 56 0.5× 41 0.6× 33 821
Lorena Alba‐Castellón Spain 16 181 0.5× 426 1.8× 245 1.2× 56 0.5× 90 1.4× 30 703
Jane E. Willoughby United Kingdom 11 412 1.2× 146 0.6× 233 1.2× 122 1.2× 34 0.5× 12 581
Ruth Eytner Germany 7 338 1.0× 240 1.0× 119 0.6× 29 0.3× 149 2.3× 7 651

Countries citing papers authored by Thomas C. Manning

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Manning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Manning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Manning more than expected).

Fields of papers citing papers by Thomas C. Manning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Manning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Manning. The network helps show where Thomas C. Manning may publish in the future.

Co-authorship network of co-authors of Thomas C. Manning

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Manning. A scholar is included among the top collaborators of Thomas C. Manning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Manning. Thomas C. Manning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mikheev, Andrei M., Svetlana A. Mikheeva, Andrew D. Trister, et al.. (2014). Periostin is a novel therapeutic target that predicts and regulates glioma malignancy. Neuro-Oncology. 17(3). 372–382. 69 indexed citations
2.
Nichols, Frank C., et al.. (2009). Unique Lipids from a Common Human Bacterium Represent a New Class of Toll-Like Receptor 2 Ligands Capable of Enhancing Autoimmunity. American Journal Of Pathology. 175(6). 2430–2438. 69 indexed citations
3.
Manning, Thomas C., et al.. (2008). SURVIVAL WITH GOOD OUTCOME AFTER TRAVERSING BRAINSTEM INJURY. Neurosurgery. 62(3). E749–E749. 3 indexed citations
4.
Manning, Thomas C., Anthony M. Avellino, Jordan M. Symons, Jeffrey G. Ojemann, & Richard G. Ellenbogen. (2007). Cerebrospinal Fluid Shunting in Children on Renal Dialysis. Pediatric Neurosurgery. 44(1). 65–67. 1 indexed citations
5.
Manning, Thomas C., Donald E. Born, & Trent L. Tredway. (2006). SPINAL INTRAMEDULLARY HISTOPLASMOSIS AS THE INITIAL PRESENTATION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION. Neurosurgery. 59(5). E1146–E1146. 3 indexed citations
6.
Elias, Maria Carolina, John R. Silber, Svetlana A. Mikheeva, et al.. (2005). TWIST is Expressed in Human Gliomas, Promotes Invasion. Neoplasia. 7(9). 824–837. 153 indexed citations
7.
Brinkman, William T., Wendy A. Cohen, & Thomas C. Manning. (2003). Posterior Fossa Subarachnoid Hemorrhage Due to an Atlantooccipital Dislocation. American Journal of Roentgenology. 180(5). 1476–1476. 5 indexed citations
8.
Tschoep, Katharina, Thomas C. Manning, Helena Harlin, et al.. (2003). Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. Journal of Leukocyte Biology. 74(1). 69–80. 18 indexed citations
9.
Rund, Laurie A., Bryan K. Cho, Thomas C. Manning, et al.. (1999). Bispecific agents target endogenous murine T cells against human tumor xenografts. International Journal of Cancer. 83(1). 141–149. 23 indexed citations
10.
Manning, Thomas C. & David M. Kranz. (1999). Binding energetics of T-cell receptors: correlation with immunological consequences. Immunology Today. 20(9). 417–422. 28 indexed citations
11.
Manning, Thomas C., et al.. (1999). Effects of Complementarity Determining Region Mutations on the Affinity of an α/β T Cell Receptor: Measuring the Energy Associated with CD4/CD8 Repertoire Skewing. The Journal of Experimental Medicine. 189(3). 461–470. 29 indexed citations
12.
Kranz, David M., et al.. (1998). Targeting tumor cells with bispecific antibodies and T cells. Journal of Controlled Release. 53(1-3). 77–84. 18 indexed citations
13.
Manning, Thomas C., Carol J. Schlueter, Thomas C. Brodnicki, et al.. (1998). Alanine Scanning Mutagenesis of an αβ T Cell Receptor: Mapping the Energy of Antigen Recognition. Immunity. 8(4). 413–425. 151 indexed citations
14.
Manning, Thomas C., et al.. (1997). Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice. The Journal of Immunology. 159(10). 4665–4675. 49 indexed citations
15.
Manning, Thomas C., Beth A. Schodin, & David M. Kranz. (1996). A strategy for the synthesis and screening of thiol-modified peptide variants recognized by T cells. Journal of Immunological Methods. 192(1-2). 125–132. 5 indexed citations
16.
Schlueter, Carol J., Thomas C. Manning, Beth A. Schodin, & David M. Kranz. (1996). A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor. The Journal of Immunology. 157(10). 4478–4485. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026